Genexine and KGbio received the first market approval for novel long-acting Erythropoietin, Efepoetin alfa, from The Indonesian Food and Drug Authority (BPOM)
SEOUL, South Korea--(BUSINESS WIRE)--Oct 23, 2023--
Stay updated with breaking news from Distribution Logistics Division. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
SEOUL, South Korea--(BUSINESS WIRE)--Oct 23, 2023--
/PRNewswire/ -- Shanghai Henlius Biotech, Inc. (2696.HK) has entered into an exclusive license agreement with PT Kalbe Genexine Biologics ("KGbio"), an...
Jakarta, May 3rd, 2023 - PT Kalbe Farma Tbk will distribute cash dividend of Rp 1.76 trillion or 38 per share. The distribution of cash dividend has been approved by the Shareholders... | May 4, 2023
Jakarta, April 28, 2023 - PT Kalbe Farma Tbk and Subsidiaries today announced that net sales reached Rp 7,869 billion in the first quarter of 2023, growing by 12.2% compared to the... | April 28, 2023